Profitability Ratios
| Ratio |
Value |
| GP Margin |
63.3% |
| EBIT Margin |
11.0% |
| EBITDA Margin |
15.0% |
| Operating Margin |
11.0% |
| Pretax Margin |
6.4% |
| Cont. Ops Margin |
4.7% |
| Net Margin |
4.7% |
| Bottom Line Margin |
4.7% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
3.04 |
| Quick Ratio |
3.04 |
| Solvency Ratio |
0.195 |
| Cash Ratio |
1.10 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.35 |
| Forward PEG |
-0.35 |
| Price/Book |
1.77 |
| Price/Sales |
2.08 |
| Price/FCF |
12.19 |
| Price/Op Cash Flow |
12.16 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1475 |
| Debt/Equity |
0.2035 |
| Debt/Capital |
0.1691 |
| Long-Term Debt/Capital |
0.1431 |
| Financial Leverage |
1.38 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.78 |
| Operating Cash Flow Ratio |
0.880 |
| Operating Cash Flow/Sales |
17.1% |
| Free Cash Flow/Operating Cash Flow |
99.7% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.50 |
| Interest Coverage |
2.2782 |
| Short-Term Operating Cash Flow Coverage |
4.21 |
| Operating Cash Flow Coverage |
0.72 |
| Capital Expenditure Coverage |
322.67 |
| Dividend + Capital Expenditure Coverage |
322.67 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
5.90 |
| EPS |
0.277 |
| Debt/Share |
1.6921 |
| Cash/Share |
1.26 |
| Book Value/Share |
6.91 |
| Tangible BV/Share |
0.90 |
| Equity/Share |
6.91 |
| Operating Cash Flow/Share |
1.009 |
| Capital Expenditure/Share |
0.003 |
| FCF/Share |
1.005 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.738 |
| Earnings Before Tax/EBIT |
0.576 |
| Price/Fair Value |
1.77 |
| Debt/Market Cap |
0.1137 |
| Effective Tax Rate |
26.2% |
| Enterprise Value Multiple |
14.05 |
OPRX - OptimizeRx Corporation